
InterCure Ltd Investor Relations Material
Latest events

Q4 2022
InterCure Ltd

Q4 2023
1 May, 2024

Q2 2023
31 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InterCure Ltd
Access all reports
InterCure Ltd is a pharmaceutical company focused on the production and distribution of medical cannabis products. Through its subsidiary, Canndoc, the company cultivates and manufactures pharmaceutical-grade cannabis used for medical treatments. InterCure offers a range of cannabis-based products, including oils, flowers, and other formulations designed for therapeutic purposes. The company partners with international healthcare and cannabis companies to expand its product offerings and distribution channels in global markets where medical cannabis is regulated. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
INCR
Country
🇺🇸 United States